1,465 reports of this reaction
3.1% of all OXAZEPAM reports
#2 most reported adverse reaction
FALL is the #2 most commonly reported adverse reaction for OXAZEPAM, manufactured by Actavis Pharma, Inc.. There are 1,465 FDA adverse event reports linking OXAZEPAM to FALL. This represents approximately 3.1% of all 46,840 adverse event reports for this drug.
Patients taking OXAZEPAM who experience fall should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FALL is moderately reported among OXAZEPAM users, representing a notable but not dominant share of adverse events.
In addition to fall, the following adverse reactions have been reported for OXAZEPAM:
The following drugs have also been linked to fall in FDA adverse event reports:
FALL has been reported as an adverse event in 1,465 FDA reports for OXAZEPAM. This does not prove causation, but indicates an association observed in post-market surveillance data.
FALL accounts for approximately 3.1% of all adverse event reports for OXAZEPAM, making it one of the most commonly reported side effect.
If you experience fall while taking OXAZEPAM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.